Literature DB >> 17404007

Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1.

J M Rodríguez-Martínez1, C Velasco, I García, M E Cano, L Martínez-Martínez, A Pascual.   

Abstract

The influence of qnrA1 on the development of quinolone resistance in Enterobacteriaceae was evaluated by using the mutant prevention concentration parameter. The expression of qnrA1 considerably increased the mutant prevention concentration compared to strains without this gene. In the presence of qnrA1, mutations in gyrA and parC genes were easily selected to produce high levels of quinolone resistance.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17404007      PMCID： PMC1891403          DOI： 10.1128/AAC.01444-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

1.  Interaction of plasmid and host quinolone resistance.

Authors:  Luis Martínez-Martínez; Alvaro Pascual; Isabel García; John Tran; George A Jacoby
Journal:  J Antimicrob Chemother       Date:  2003-02-25       Impact factor: 5.790

Review 2.  The mutant selection window and antimicrobial resistance.

Authors:  Karl Drlica
Journal:  J Antimicrob Chemother       Date:  2003-06-12       Impact factor: 5.790

3.  Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe.

Authors:  Hedi Mammeri; Marc Van De Loo; Laurent Poirel; Luis Martinez-Martinez; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 4.  Pharmacokinetics and pharmacodynamics of fluoroquinolones.

Authors:  J Turnidge
Journal:  Drugs       Date:  1999       Impact factor: 9.546

5.  Quinolone resistance from a transferable plasmid.

Authors:  L Martínez-Martínez; A Pascual; G A Jacoby
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

Review 6.  Strategies to minimize the development of antibiotic resistance.

Authors:  F Baquero; M C Negri
Journal:  J Chemother       Date:  1997-05       Impact factor: 1.714

7.  Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China.

Authors:  Minggui Wang; John H Tran; George A Jacoby; Yingyuan Zhang; Fu Wang; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

8.  Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase.

Authors:  J M Rodríguez-Martínez; A Pascual; I García; L Martínez-Martínez
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790

9.  Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.

Authors:  Dieter Boy; Michaela Well; Martina Kinzig-Schippers; Fritz Sörgel; Dorothe Ankel-Fuchs; Kurt G Naber
Journal:  Int J Antimicrob Agents       Date:  2004-03       Impact factor: 5.283

10.  Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and beta-lactam antimicrobial agents.

Authors:  J S Wolfson; D C Hooper; G L McHugh; M A Bozza; M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191
View more
  27 in total

1.  Fluoroquinolone Resistance in Salmonella and the Utility of Pefloxacin Disk Diffusion [corrected].

Authors:  Ferric C Fang
Journal:  J Clin Microbiol       Date:  2015-08-26       Impact factor: 5.948

2.  Mechanisms of reduced susceptibility to ciprofloxacin in Escherichia coli isolates from Canadian hospitals.

Authors:  Patricia J Baudry-Simner; Amanpreet Singh; James A Karlowsky; Daryl J Hoban; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

Review 3.  Plasmid-mediated quinolone resistance.

Authors:  George A Jacoby; Jacob Strahilevitz; David C Hooper
Journal:  Microbiol Spectr       Date:  2014-10

Review 4.  Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries.

Authors:  B Yanat; J-M Rodríguez-Martínez; A Touati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-26       Impact factor: 3.267

5.  In vitro effect of qnrA1, qnrB1, and qnrS1 genes on fluoroquinolone activity against isogenic Escherichia coli isolates with mutations in gyrA and parC.

Authors:  A Briales; J M Rodríguez-Martínez; C Velasco; P Díaz de Alba; J Domínguez-Herrera; J Pachón; A Pascual
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

6.  Fluoroquinolone susceptibility testing of Salmonella enterica: detection of acquired resistance and selection of zone diameter breakpoints for levofloxacin and ofloxacin.

Authors:  Maria Sjölund-Karlsson; Rebecca L Howie; John A Crump; Jean M Whichard
Journal:  J Clin Microbiol       Date:  2014-01-03       Impact factor: 5.948

Review 7.  Drug interactions and the evolution of antibiotic resistance.

Authors:  Pamela J Yeh; Matthew J Hegreness; Aviva Presser Aiden; Roy Kishony
Journal:  Nat Rev Microbiol       Date:  2009-06       Impact factor: 60.633

8.  Quinolone co-resistance in ESBL- or AmpC-producing Escherichia coli from an Indian urban aquatic environment and their public health implications.

Authors:  Priyanka Bajaj; Pawan Kumar Kanaujia; Nambram Somendro Singh; Shalu Sharma; Shakti Kumar; Jugsharan Singh Virdi
Journal:  Environ Sci Pollut Res Int       Date:  2015-10-26       Impact factor: 4.223

Review 9.  Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance.

Authors:  David C Hooper; George A Jacoby
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

10.  Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection.

Authors:  Nicolas Allou; Emmanuelle Cambau; Laurent Massias; Françoise Chau; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2009-07-27       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.